BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 13130506)

  • 21. Long-term stable expression of antisense cDNA of cyclin B1 profoundly inhibits the proliferation of tumor cells and suppresses tumorigenicity in implanted mice.
    Zhang T; Zhang L; Li JC; Wei D; Wei YQ; Zhang R; Cheng P; Chen XC; Liu HY; Su XM
    Chin Med J (Engl); 2008 Aug; 121(15):1433-8. PubMed ID: 18959122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of antisense glial fibrillary acidic protein complementary DNA on the growth, invasion, and adhesion of human astrocytoma cells.
    Rutka JT; Hubbard SL; Fukuyama K; Matsuzawa K; Dirks PB; Becker LE
    Cancer Res; 1994 Jun; 54(12):3267-72. PubMed ID: 8205549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CpG immunomer DNA enhances antisense protein kinase A RIalpha inhibition of multidrug-resistant colon carcinoma growth in nude mice: molecular basis for combinatorial therapy.
    Nesterova MV; Johnson NR; Stewart T; Abrams S; Cho-Chung YS
    Clin Cancer Res; 2005 Aug; 11(16):5950-5. PubMed ID: 16115938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced apoptosis following treatment with TRA-8 anti-human DR5 monoclonal antibody and overexpression of exogenous Bax in human glioma cells.
    Kaliberov S; Stackhouse MA; Kaliberova L; Zhou T; Buchsbaum DJ
    Gene Ther; 2004 Apr; 11(8):658-67. PubMed ID: 14973547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of antisense VEGF cDNA transfection on the growth of chronic myeloid leukemia K562 cells in vitro and in nude mice.
    Ruan GR; Liu YR; Chen SS; Fu JY; Chang Y; Qin YZ; Li JL; Yu H; Wang H
    Leuk Res; 2004 Jul; 28(7):763-9. PubMed ID: 15158098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Inhibitory effect of bcl-2 antisense oligodeoxynucleotides on growth of human lung carcinoma xenograft in nude mice].
    He DM; Zhang H
    Ai Zheng; 2006 Jan; 25(1):40-4. PubMed ID: 16405747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Forced expression of antisense 14-3-3beta RNA suppresses tumor cell growth in vitro and in vivo.
    Sugiyama A; Miyagi Y; Komiya Y; Kurabe N; Kitanaka C; Kato N; Nagashima Y; Kuchino Y; Tashiro F
    Carcinogenesis; 2003 Sep; 24(9):1549-59. PubMed ID: 12896901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: effects on gene expression and growth of glioma cells in vitro and in vivo.
    Yin D; Ong JM; Hu J; Desmond JC; Kawamata N; Konda BM; Black KL; Koeffler HP
    Clin Cancer Res; 2007 Feb; 13(3):1045-52. PubMed ID: 17289901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of bcl-2 enhances the efficacy of chemotherapy in renal cell carcinoma.
    Kausch I; Jiang H; Thode B; Doehn C; Krüger S; Jocham D
    Eur Urol; 2005 May; 47(5):703-9. PubMed ID: 15826766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro and in vivo potentiation of radiosensitivity of malignant gliomas by antisense inhibition of the RAD51 gene.
    Ohnishi T; Taki T; Hiraga S; Arita N; Morita T
    Biochem Biophys Res Commun; 1998 Apr; 245(2):319-24. PubMed ID: 9571148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
    Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M
    Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The chemokine GRO-alpha (CXCL1) confers increased tumorigenicity to glioma cells.
    Zhou Y; Zhang J; Liu Q; Bell R; Muruve DA; Forsyth P; Arcellana-Panlilio M; Robbins S; Yong VW
    Carcinogenesis; 2005 Dec; 26(12):2058-68. PubMed ID: 16033775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of human non-small cell lung tumors by a c-Met antisense/U6 expression plasmid strategy.
    Stabile LP; Lyker JS; Huang L; Siegfried JM
    Gene Ther; 2004 Feb; 11(3):325-35. PubMed ID: 14737093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inhibitory effects of bcl-xl antisense oligodeoxynucleotides on growth of human nasopharyngeal carcinoma in nude mice].
    Min L; Zhou KY; Liang T; Zhang YF
    Zhonghua Zhong Liu Za Zhi; 2004 Jan; 26(1):14-7. PubMed ID: 15059344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induced expression and subcellular localization of the Bcl-2 protein in cultured glioma cells.
    Kihara S; Shiraishi T; Nakagawa S; Tabuchi K
    Noshuyo Byori; 1994; 11(2):161-7. PubMed ID: 7894619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bcl-2 antisense oligonucleotides chemosensitize human gastric cancer in a SCID mouse xenotransplantation model.
    Wacheck V; Heere-Ress E; Halaschek-Wiener J; Lucas T; Meyer H; Eichler HG; Jansen B
    J Mol Med (Berl); 2001 Oct; 79(10):587-93. PubMed ID: 11692156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flavopiridol potentiates the cytotoxic effects of radiation in radioresistant tumor cells in which p53 is mutated or Bcl-2 is overexpressed.
    Hara T; Omura-Minamisawa M; Kang Y; Cheng C; Inoue T
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1485-95. PubMed ID: 18640498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins.
    Tagscherer KE; Fassl A; Campos B; Farhadi M; Kraemer A; Böck BC; Macher-Goeppinger S; Radlwimmer B; Wiestler OD; Herold-Mende C; Roth W
    Oncogene; 2008 Nov; 27(52):6646-56. PubMed ID: 18663354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BCL-xL: time-dependent dissociation between modulation of apoptosis and invasiveness in human malignant glioma cells.
    Weiler M; Bähr O; Hohlweg U; Naumann U; Rieger J; Huang H; Tabatabai G; Krell HW; Ohgaki H; Weller M; Wick W
    Cell Death Differ; 2006 Jul; 13(7):1156-69. PubMed ID: 16254573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of lung tumor growth and augmentation of radiosensitivity by decreasing peroxiredoxin I expression.
    Chen MF; Keng PC; Shau H; Wu CT; Hu YC; Liao SK; Chen WC
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):581-91. PubMed ID: 16414373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.